← Back to Treatments
🏅 FDA Orphan Designation

EBANGA�

ansuvimab-zykl

Manufacturer: Emergent Manufacturing Operations Baltimore LLC

Indicated for:
Ebola hemorrhagic feverOrphanZika virus diseaseOrphanAccel.

FDA-Approved Indications (2)

Ebola hemorrhagic feverOrphan Designation

treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection

Zika virus diseaseOrphan DesignationAccelerated Approval

treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection

Population: adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection

Indications & Usage

treatment of infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection

💙 Support Programs

View all →
EBANGA�
Emergent Manufacturing Operations Baltimore LLC
EBANGA�
Emergent Manufacturing Operations Baltimore LLC

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.